The Effect of Food on the Single-Dose Bioavailability and Tolerability of the Highest Marketed Strength of Duloxetine.

Clin Pharmacol Drug Dev 2020 10 2;9(7):797-804. Epub 2019 Dec 2.

Medochemie Ltd, Limassol, Cyprus.

Duloxetine is a combined serotonin and norepinephrine reuptake inhibitor indicated in adults for the treatment of major depressive disorder, diabetic peripheral neuropathic pain, and generalized anxiety disorder. The aim of these studies was to evaluate the effect of food on the pharmacokinetics and safety of duloxetine 60-mg gastroresistant hard capsules following single-dose administration. The data were obtained from 2 phase 1 bioequivalence studies, 1 in a fasting state and the other under fed conditions. Both studies have shown that, when administered as a single dose in the same prandial state, the test and reference duloxetine treatments were bioequivalent and exhibited similar safety profiles. The mean fed and fasting pharmacokinetic parameters and drug-related adverse events from the 2 studies were compared in order to assess the effect of food on the duloxetine bioavailability and respectively, tolerability. Administration of duloxetine in fed conditions increased peak plasma concentration by up to 30% and delayed mean time to peak concentration by an average of 1.15 hours while having an insignificant effect on extent of absorption (area under the plasma concentration-time curve in fed state within ±6% as compared with fasting conditions). Even though peak plasma levels were substantially higher in the fed state, there was no negative impact on the drug's safety profile. Actually, administration with food resulted in a lower average number of adverse events per single dose exposure. The negligible variation in overall systemic exposure suggests that efficacy remains unchanged irrespective of administration conditions; however, a better tolerability of the 60-mg dose is expected when the drug is taken with food.

Download full-text PDF

Source
http://dx.doi.org/10.1002/cpdd.759DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586977PMC
October 2020

Publication Analysis

Top Keywords

fed state
8
fed conditions
8
peak plasma
8
single dose
8
bioavailability tolerability
8
adverse events
8
duloxetine
6
fed
5
food
5
exhibited safety
4
bioequivalent exhibited
4
profiles fed
4
fasting pharmacokinetic
4
safety profiles
4
food lower
4
fed fasting
4
administration food
4
studies compared
4
profile administration
4
events studies
4

Similar Publications